Inspira Technologies (Nasdaq: IINN) deploys AME platform with top-10 U.S. company

Rhea-AI Filing Summary

Inspira Technologies OXY B.H.N. Ltd. has begun implementing its AME (Additive Manufactured Electronics) technology with a customer described as one of the world's 10 largest U.S.-based companies. The rollout is underway at a U.S. research and development facility integrated into an advanced corporate technology infrastructure.

The engagement focuses on using Inspira’s AME platform for cryogenic connectivity in quantum computing, addressing critical scaling bottlenecks. Inspira views this as validation of its AME technology, reinforcing a recurring revenue relationship and signaling broader demand from elite technology organizations, while it continues to develop its medical technology portfolio.

Insights

Technology and growth-stage analyst

Inspira advances AME platform with a top-tier U.S. tech customer, signaling strategic progress but with unquantified financial impact.

Inspira Technologies has moved from concept to practical deployment of its AME platform by commencing implementation with a customer ranked among the world's 10 largest U.S.-based companies. The work centers on quantum computing cryogenic connectivity, a key bottleneck in scaling quantum systems.

This engagement occurs inside a major U.S. research and development facility, suggesting deep technical integration. The company characterizes the relationship as recurring revenue-generating activity and high-level validation of its technology, though no contract size or duration is disclosed in the text.

Strategically, Inspira positions AME at the intersection of quantum hardware and advanced computing infrastructure while maintaining a separate medical technology business unit. Future disclosures in periodic reports may clarify how this implementation and related opportunities translate into revenue mix and overall business focus.

Key Terms

Additive Manufactured Electronics, cryogenic connectivity, dilution cryostats, forward-looking statements, +2 more

6 terms

Additive Manufactured Electronics technical

"following its acquisition of the AME (Additive Manufactured Electronics) business"

Additive manufactured electronics are electronic circuits and devices created by depositing conductive ink and other materials layer by layer using 3D-printing techniques, rather than by traditional etching or assembly. For investors, this matters because it can cut production time and tooling costs, enable rapid customization and smaller production runs, and change supply-chain dynamics—potentially boosting margins or creating new competitive advantages, while also bringing scale-up and quality risks.

cryogenic connectivity technical

"entry into the cryogenic connectivity space for quantum computing"

Cryogenic connectivity describes the cables, connectors and signal pathways designed to carry electrical power and data reliably at extremely low temperatures, often well below freezing, where materials behave very differently. For investors it matters because these specialized links enable high-performance technologies—such as quantum computers and ultra-sensitive sensors—to function, scale and stay reliable; think of them like insulated plumbing that must keep water flowing without leaks in a deep-freeze, affecting product viability, manufacturing costs and supply-chain risk.

dilution cryostats technical

"designed for high-density, thermally optimized operation in dilution cryostats"

A dilution cryostat is a laboratory machine that creates extremely low temperatures—thousandths of a degree above absolute zero—by using a special mixture of helium isotopes. Think of it as a super-powerful freezer that lets researchers test and run delicate technologies such as quantum processors and ultra-sensitive sensors. For investors, access to or development of these systems signals involvement in advanced, capital-intensive technologies with long development cycles and potential for high strategic value.

forward-looking statements regulatory

"This press release contains express or implied forward-looking statements"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

Registration Statements on Form F-3 regulatory

"incorporated by reference into the Company’s Registration Statements on Form F-3"

Form 20-F regulatory

"contained under the heading “Risk Factors” in the Company’s annual report on Form 20-F"

Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of April 2026 (Report No. 3)

Commission File Number: 001-40303

Inspira Technologies Oxy B.H.N. Ltd.

(Translation of registrant’s name into English)

2 Ha-Tidhar St.

Ra’anana 4366504, Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F      ☐ Form 40-F

CONTENTS

On April 13, 2026, Inspira Technologies Oxy B.H.N. Ltd. (the “Company”) issued a press release titled “Inspira Begins AME Technology Implementation Process with One of the World's 10 Largest U.S. Based Companies,” a copy of which is furnished as Exhibit 99.1 with this Report of Foreign Private Issuer on Form 6-K (this “Report”).

Inspira Begins AME Technology Implementation Process with One of the World's 10 Largest U.S. Based Companies

The first, second, third and fifth paragraphs, as well as the section titled “Forward-Looking Statement Disclaimer,” of the press release are incorporated by reference into the Company’s Registration Statements on Form F-3 (Registration Nos. 333-284308 and 333-289324) and Form S-8 (Registration Nos. 333-259057, 333-277980, 333-285565, 333-290162 and 333-292592), filed with the Securities and Exchange Commission, to be a part thereof from the date on which this Report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

Exhibit No.
99.1		Press Release issued by Inspira Technologies Oxy B.H.N. Ltd. on April 13, 2026, titled “Inspira Begins AME Technology Implementation Process with One of the World's 10 Largest U.S. Based Companies.”

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Inspira Technologies Oxy B.H.N. Ltd.
Date: April 13, 2026	By:	/s/ Dagi Ben-Noon
		Name:	Dagi Ben-Noon
		Title:	Chief Executive Officer

2

Exhibit 99.1

Inspira Begins AME Technology Implementation Process with One of the World's 10 Largest U.S. Based Companies

RA'ANANA, Israel, April 13, 2026 -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), today announced the commencement of an AME technology implementation with a customer that is one of the world's 10 largest U.S.-based companies. This engagement marks a significant step in the practical execution of the Company's strategic expansion into advanced technology markets following its acquisition of the AME (Additive Manufactured Electronics) business, including Inspira's entry into the cryogenic connectivity space for quantum computing, where the AME platform is being leveraged to address one of the most critical scaling bottlenecks facing the quantum industry today.

The rollout has already commenced and is focused on advancing Inspira's AME technology at a U.S. research and development facility, integrated into one of the world's most advanced corporate technology infrastructures. The customer operates at the forefront of artificial intelligence, computing infrastructure, and platform technologies globally.

The Company believes this implementation process provides high-level validation of its AME platform and reflects ongoing commercial engagement with a customer operating at the highest tier of the global corporate technology landscape. Importantly, this engagement reinforces recurring revenue-generating activity associated with that customer relationship. Furthermore, the process demonstrates broader demand from elite technology organizations for solutions addressing next-generation hardware connectivity and integration challenges.

"We view this type of engagement as confirmation of the practical relevance of our AME platform," said Dagi Ben-Noon, Chief Executive Officer of Inspira. "We are not speaking about theoretical potential. We are engaged in an active implementation process with a paying customer ranked among the largest companies in the world, a company with the resources, expertise, and infrastructure to validate our AME technology at the highest level. We view this engagement as an important signal of where this platform can go."

Inspira believes that the customer’s participation in this type of implementation process supports additional strategic opportunities and further strengthens the positioning of its AME platform across advanced technology markets.

About Inspira Technologies

Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) is a technology company focused on solving the most critical physical and hardware bottlenecks in quantum computing connectivity. Inspira develops unique quantum connectivity solutions designed for high-density, thermally optimized operation in dilution cryostats, a prerequisite for scaling quantum systems beyond current physical limitations. Additionally, the Company continues to advance its medical technology portfolio, including its respiratory support and blood monitoring platforms under a dedicated business unit. For more information, please visit: www.q-trex.com and www.inspira-technologies.com

Forward-Looking Statement Disclaimer

This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses the potential for its AME technology and business, that its AME platform is being leveraged to address one of the most critical scaling bottlenecks facing the quantum industry today, the belief that the contract implementation provides high-level validation of its AME platform, reflects ongoing commercial engagement with a customer operating at the highest tier of the global corporate technology landscape, reinforces recurring revenue-generating activity associated with that customer relationship and that it demonstrates broader demand from elite technology organizations for solutions addressing next-generation hardware connectivity and integration challenges, that it views the engagement as confirmation of the practical relevance of our AME platform and as an important signal of where its AME platform can go and its belief that the customer’s participation in this type of implementation process supports additional strategic opportunities and further strengthens the positioning of its AME platform across advanced technology markets. These forward-looking statements and their implications are based solely on the current expectations of the Company’s management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading “Risk Factors” in the Company’s annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the “SEC”), which is available on the SEC’s website at www.sec.gov.

Company Contact
Inspira Technologies
Email: info@inspirao2.com
Phone: +972-9-9664485

Investor Relations Contact
Arx Investor Relations
North American Equities Desk
inspira@arxhq.com

FAQ

What did Inspira Technologies (IINN) announce in this Form 6-K?

Inspira Technologies announced it has begun implementing its AME technology with a customer that is one of the world's 10 largest U.S.-based companies. The project focuses on deploying AME within a U.S. research and development facility, marking a key step in its advanced technology strategy.

How does the new AME implementation impact Inspira Technologies (IINN)?

The AME implementation with a top-tier U.S. customer provides validation of Inspira’s AME platform and reflects ongoing commercial engagement. It reinforces a recurring revenue-generating relationship and supports broader positioning of the technology across advanced markets, particularly in quantum computing connectivity solutions.

What technology focus did Inspira Technologies (IINN) highlight in this update?

Inspira highlighted its focus on solving physical and hardware bottlenecks in quantum computing connectivity using its AME platform. The technology targets high-density, thermally optimized operation inside dilution cryostats, which is described as essential for scaling quantum systems beyond current physical limits.

Which type of customer is working with Inspira Technologies (IINN) on AME?

The customer is described as one of the world's 10 largest U.S.-based companies, operating at the forefront of artificial intelligence, computing infrastructure, and platform technologies. The collaboration involves integrating AME technology into one of the most advanced corporate technology infrastructures globally.

Does Inspira Technologies (IINN) still maintain its medical technology business?

Yes. Inspira continues to advance its medical technology portfolio alongside its quantum connectivity efforts. The company maintains respiratory support and blood monitoring platforms within a dedicated business unit, while separately developing its AME-based quantum computing connectivity solutions.

What risks or uncertainties did Inspira Technologies (IINN) note about its AME platform?

Inspira included forward-looking statements indicating that expectations about its AME platform and related opportunities involve risks and uncertainties. Actual results may differ materially, and investors are directed to the company’s Form 20-F risk factors for more detailed discussion of these potential risks.

Filing Exhibits & Attachments

2 documents

Press Releases

• EX-99.1 EXHIBIT 99.1 11.1 KB
• EX-99 GRAPHIC 9.9 KB